Literature DB >> 24399556

Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation.

Benjamin Lê Cook1, Geoff Ferris Wayne1, E Nilay Kafali1, Zimin Liu2, Chang Shu3, Michael Flores4.   

Abstract

IMPORTANCE: Significant progress has been made in reducing the prevalence of tobacco use in the United States. However, tobacco cessation efforts have focused on the general population rather than individuals with mental illness, who demonstrate greater rates of tobacco use and nicotine dependence.
OBJECTIVES: To assess whether declines in tobacco use have been realized among individuals with mental illness and examine the association between mental health treatment and smoking cessation. DESIGN, SETTING, AND PARTICIPANTS: Use of nationally representative surveys of noninstitutionalized US residents to compare trends in smoking rates between adults with and without mental illness and across multiple disorders (2004-2011 Medical Expenditure Panel Survey [MEPS]) and to compare rates of smoking cessation among adults with mental illness who did and did not receive mental health treatment (2009-2011 National Survey of Drug Use and Health [NSDUH]).The MEPS sample included 32,156 respondents with mental illness (operationalized as reporting severe psychological distress, probable depression, or receiving treatment for mental illness) and 133,113 without mental illness. The NSDUH sample included 14,057 lifetime smokers with mental illness. MAIN OUTCOMES AND MEASURES: Current smoking status (primary analysis; MEPS sample) and smoking cessation, operationalized as a lifetime smoker who did not smoke in the last 30 days (secondary analysis; NSDUH sample).
RESULTS: Adjusted smoking rates declined significantly among individuals without mental illness (19.2% [95% CI, 18.7-19.7%] to 16.5% [95% CI, 16.0%-17.0%]; P < .001) but changed only slightly among those with mental illness (25.3% [95% CI, 24.2%-26.3%] to 24.9% [95% CI, 23.8%- 26.0%]; P = .50), a significant difference in difference of 2.3% (95% CI, 0.7%-3.9%) (P = .005). Individuals with mental illness who received mental health treatment within the previous year were more likely to have quit smoking (37.2% [95% CI, 35.1%-39.4%]) than those not receiving treatment (33.1% [95% CI, 31.5%-34.7%]) (P = .005). CONCLUSIONS AND RELEVANCE: Between 2004 and 2011, the decline in smoking among individuals with mental illness was significantly less than among those without mental illness, although quit rates were greater among those receiving mental health treatment. This suggests that tobacco control policies and cessation interventions targeting the general population have not worked as effectively for persons with mental illness.

Entities:  

Mesh:

Year:  2014        PMID: 24399556      PMCID: PMC5555156          DOI: 10.1001/jama.2013.284985

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year.

Authors:  Ricardo F Muñoz; Alinne Z Barrera; Kevin Delucchi; Carlos Penilla; Leandro D Torres; Eliseo J Pérez-Stable
Journal:  Nicotine Tob Res       Date:  2009-07-29       Impact factor: 4.244

3.  Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?

Authors:  Judith J Prochaska
Journal:  Drug Alcohol Depend       Date:  2010-04-07       Impact factor: 4.492

4.  Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.

Authors:  Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori
Journal:  JAMA       Date:  2010-12-08       Impact factor: 56.272

5.  Tobacco control policy in developed countries: yesterday, today, and tomorrow.

Authors:  Kenneth E Warner; David Mendez
Journal:  Nicotine Tob Res       Date:  2010-08-11       Impact factor: 4.244

Review 6.  Smoking bans in psychiatric inpatient settings? A review of the research.

Authors:  Sharon Lawn; Rene Pols
Journal:  Aust N Z J Psychiatry       Date:  2005-10       Impact factor: 5.744

7.  Tobacco use among those with serious psychological distress: results from the national survey of drug use and health, 2002.

Authors:  Brett T Hagman; Cristine D Delnevo; Mary Hrywna; Jill M Williams
Journal:  Addict Behav       Date:  2007-11-17       Impact factor: 3.913

8.  The role of provider supply and organization in reducing racial/ethnic disparities in mental health care in the U.S.

Authors:  Benjamin Lê Cook; Teresa Doksum; Chih-Nan Chen; Adam Carle; Margarita Alegría
Journal:  Soc Sci Med       Date:  2013-02-13       Impact factor: 4.634

Review 9.  Assessing motivation to quit smoking in people with mental illness: a review.

Authors:  Ranita Siru; Gary K Hulse; Robert J Tait
Journal:  Addiction       Date:  2009-05       Impact factor: 6.526

10.  Current cigarette smoking among adults - United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-11-09       Impact factor: 17.586

View more
  180 in total

1.  Evaluation of Community-Based Cessation Programs: How Do Smokers with Behavioral Health Conditions Fare?

Authors:  Clare Meernik; Anna McCullough; Leah Ranney; Barbara Walsh; Adam O Goldstein
Journal:  Community Ment Health J       Date:  2017-08-02

2.  Predictors of Tobacco Use Among New York State Addiction Treatment Patients.

Authors:  Joseph Guydish; Jiang Yu; Thao Le; Anna Pagano; Kevin Delucchi
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

3.  Integrated care models and behavioral health care utilization: Quasi-experimental evidence from Medicaid health homes.

Authors:  Chandler McClellan; Johanna Catherine Maclean; Brendan Saloner; Emma E McGinty; Michael F Pesko
Journal:  Health Econ       Date:  2020-04-22       Impact factor: 3.046

4.  Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder.

Authors:  Lirio S Covey; Mei-Chen Hu; Theresa Winhusen; Jennifer Lima; Ivan Berlin; Edward Nunes
Journal:  J Subst Abuse Treat       Date:  2015-07-17

5.  The Role of Neighborhood Experiences in Psychological Distress among African American and White Smokers.

Authors:  Taneisha S Scheuermann; Jarron M Saint Onge; Megha Ramaswamy; Lisa Sanderson Cox; Jasjit S Ahluwalia; Nicole L Nollen
Journal:  Race Soc Probl       Date:  2020-01-11

6.  The unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance use.

Authors:  Conall O'Cleirigh; Sarah E Valentine; Megan Pinkston; Debra Herman; C Andres Bedoya; Janna R Gordon; Steven A Safren
Journal:  AIDS Behav       Date:  2015-01

7.  Modeling smoking-attributable mortality among adults with major depression in the United States.

Authors:  Jamie Tam; Gemma M J Taylor; Kara Zivin; Kenneth E Warner; Rafael Meza
Journal:  Prev Med       Date:  2020-08-27       Impact factor: 4.018

Review 8.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

Review 9.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

10.  A behavioral economic perspective on smoking persistence in serious mental illness.

Authors:  Jennifer W Tidey
Journal:  Prev Med       Date:  2016-05-16       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.